LONDON, January 13 /PRNewswire/ --

The European heart health ingredients market is developing lucratively due to the growth in the functional foods sector, triggered by a global fitness fad among consumers. Extensive media coverage has heightened consumer awareness about the fatality of cardiovascular disease (CVD) and the ill effects of obesity, heightening interest towards low fat and heart-healthy food products.

(Logo: http://www.newscom.com/cgi-bin/prnh/20081117/FSLOGO)

New analysis from Frost Sullivan (http://www.food.frost.com), European Heart Health Ingredients Market, finds that the market earned revenues of $545.0 million in 2008 and estimates this to reach $2.0 billion in 2014.

LONDON, January 13 /PRNewswire/ -- Unite, the largest trade union in the country, is suspending its industrial action over the imposed three-year NHS pay deal.

A joint meeting of Unite's Health Sector National Industrial Committee - attended by representatives from both the Amicus and TGWU sections - decided to defer industrial action on the pay campaign.

Unite now intends to concentrate on other aspects of the overall pay strategy, such as boosting the authority of the Staff Council, collating evidence for future pay claims, broadening the remit of the Pay Review Body (PRB), and specific employment issues, such as the recruitment and retention of pharmacists in the NHS.

NEW YORK, January 13 /PRNewswire/ --

Selerant ( www.selerant.com ) announces the extension of its relationship with Nestle in the area of the lifecycle management solution DevEX.

This further expansion of the DevEX 2.0 release will include the latest enhancements and features, a simple but robust regulatory compliance management system.

The solution provides multi-level transparency on all the recipes' lifecycles, using a graphical layout. Users will have the ability to quickly drill down into the details and easily zoom back out to the big picture. Users will also be able to take advantage of the entirely new nutritional claims and labeling sub-systems. The product is built on the new Microsoft .NET Framework platform.

About Selerant

MAIDENHEAD, England, January 13 /PRNewswire/ --

- Prevenar Vaccine to Help Protect Children Against the Leading Vaccine-Preventable Cause of Death in Young Children Worldwide

Turkey has initiated a national immunization programme (NIP) against pneumococcal disease with Wyeth's Prevenar(TM) (Pneumococcal saccharide conjugated vaccine, Adsorbed) - a vaccine which helps protect infants and young children against the seven serotypes causing the majority of pneumococcal disease worldwide. There are now more than 30 countries that include Prevenar in their childhood NIP.

GENEVA, Switzerland, January 13 /PRNewswire/ --

- Merck Serono and Apitope to Collaborate on Development and Commercialization of ATX-MS-1467, Apitope's Peptide Therapeutic for the Treatment of Multiple Sclerosis (MS)

UPPSALA, Sweden, January 13 /PRNewswire/ -- Beactica AB, the Swedish fragment-based drug discovery company, today announced a new research collaboration agreement with GE Healthcare (Chalfont St. Giles, UK), the world leading provider of molecular interaction analysis tools, and Uppsala University (Sweden). The collaboration combines Beactica's unique approach to fragment-based drug discovery and GE Healthcare's Biacore(TM) technology with enzymology expertise from Uppsala University.

(Logo: http://www.newscom.com/cgi-bin/prnh/20090113/333930 )

LONDON, January 13 /PRNewswire/ --

- Global Challenge Offers Engineering Students and Professionals Rare Opportunities to Bring Their Designs to the Marketplace

LONDON, January 13 /PRNewswire/ -- Excelsior Professional Search, a leading niche Executive Search company for financial technology solution providers, celebrates its tenth year of operation in 2009. Excelsior specialises in searches for mid to senior level appointments for technology vendors, consultancies, information and service providers in the global banking and securities industry. With clear market focus and expertise, Excelsior offers a deep sector knowledge and capability that the more generalist search companies are unable to provide.

LONDON, January 13 /PRNewswire/ --

Based on its recent analysis of the autoimmune disease diagnostics markets, Frost Sullivan recognizes Toscana Biomarkers with the 2008 European Frost Sullivan Excellence in Research Award. The company demonstrated that the incorporation of synthetically modified peptides for the validation and discovery of biomarkers aids effective diagnosis of autoimmune diseases and is also looking to adopt robust methods to identify novel diagnostic solutions.

(Logo: http://www.newscom.com/cgi-bin/prnh/20081117/FSLOGO )

LEIDEN, The Netherlands, January 13 /PRNewswire/ --

- Commercial License to Accelerate Development of New Hemostasis Breakthrough Products